326 related articles for article (PubMed ID: 18447663)
1. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
2. Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.
Zhang C; Shen G; Li H; Xin Y; Shi M; Zheng Y; Wang M; Liu Z; Zhao Y; Zhao F; Ren D; Zhao J
Spec Care Dentist; 2024; 44(2):530-541. PubMed ID: 37219080
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.
Walter C; Al-Nawas B; Frickhofen N; Gamm H; Beck J; Reinsch L; Blum C; Grötz KA; Wagner W
Head Face Med; 2010 Jul; 6():11. PubMed ID: 20615236
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.
Owosho AA; Blanchard A; Levi L; Kadempour A; Rosenberg H; Yom SK; Farooki A; Fornier M; Huryn JM; Estilo CL
J Craniomaxillofac Surg; 2016 Mar; 44(3):265-70. PubMed ID: 26782845
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.
Narongroeknawin P; Danila MI; Humphreys LG; Barasch A; Curtis JR
Spec Care Dentist; 2010; 30(2):77-82. PubMed ID: 20415805
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospital.
Baqain ZH; Sawair FA; Tamimi Z; Bsoul N; Al Edwan G; Almasad JK; Abbadi AA
Ann R Coll Surg Engl; 2010 Sep; 92(6):489-94. PubMed ID: 20522306
[TBL] [Abstract][Full Text] [Related]
7. Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Aragon-Ching JB; Ning YM; Chen CC; Latham L; Guadagnini JP; Gulley JL; Arlen PM; Wright JJ; Parnes H; Figg WD; Dahut WL
Cancer Invest; 2009 Feb; 27(2):221-6. PubMed ID: 19235596
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the jaws in 194 patients who have undergone intravenous bisphosphonate therapy in Spain.
Vidal-Real C; Pérez-Sayáns M; Suárez-Peñaranda JM; Gándara-Rey JM; García-García A
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e267-72. PubMed ID: 25662540
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-Preliminary data: Medical ozone gas insufflation in treating ONJ lesions.
Ripamonti CI; Maniezzo M; Boldini S; Pessi MA; Mariani L; Cislaghi E
J Bone Oncol; 2012 Dec; 1(3):81-7. PubMed ID: 26909261
[TBL] [Abstract][Full Text] [Related]
10. Antiresorptive and anti-angiogenic drug therapy in the pediatric population with reference to medication-related osteonecrosis of the jaw.
McLaurin WS; Francisco BJ; Hooker KJ; Sheshashayee N; Khan MTF; Triana RR; Rao MB; Pressey JG; Krishnan DG
Int J Oral Maxillofac Surg; 2024 Jun; 53(6):496-502. PubMed ID: 38030483
[TBL] [Abstract][Full Text] [Related]
11. Bisphophonates related osteonecrosis of the jaw.
Gupta S; Gupta H; Mandhyan D; Srivastava S
Natl J Maxillofac Surg; 2013 Jul; 4(2):151-8. PubMed ID: 24665168
[TBL] [Abstract][Full Text] [Related]
12. Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.
Kuchuk I; Mazzarello S; Butterfield K; Appleton A; Addison CL; Clemons M
J Bone Oncol; 2013 Feb; 2(1):38-46. PubMed ID: 26909271
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.
Rugani P; Walter C; Kirnbauer B; Acham S; Begus-Nahrman Y; Jakse N
Dent J (Basel); 2016 Sep; 4(4):. PubMed ID: 29563474
[TBL] [Abstract][Full Text] [Related]
14. Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man.
Heck K; Malinina S; Palmowski A
Klin Monbl Augenheilkd; 2024 Apr; 241(4):426-428. PubMed ID: 38653272
[No Abstract] [Full Text] [Related]
15. Osteonecrosis of the Jaw Associated with Bisphosphonates Infusion for Treatment of Plasma Cell Myeloma-A Retrospective Observational Study of Northern Portuguese Population.
Ferreira SS; Amaral JBD; Pacheco JJ; Salazar F; Monteiro L
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731207
[No Abstract] [Full Text] [Related]
16. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review.
Varun B; Sivakumar T; Nair BJ; Joseph AP
J Oral Maxillofac Pathol; 2012 May; 16(2):210-4. PubMed ID: 22923892
[TBL] [Abstract][Full Text] [Related]
17. Multiple systemic diseases complicated by bisphosphonate osteonecrosis: a case report.
Carini F; Barbano L; Saggese V; Monai D; Porcaro G
Ann Stomatol (Roma); 2012 Apr; 3(2 Suppl):32-6. PubMed ID: 23285320
[TBL] [Abstract][Full Text] [Related]
18. Decayed, Missing, and Filled Teeth Index and Periodontal Health in Osteoporotic Patients Affected by BRONJ: An Observational Study.
Oteri G; Bramanti E; Nigrone V; Cicciù M
J Osteoporos; 2013; 2013():231289. PubMed ID: 24455411
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate related osteonecrosis of the jaw: a study of 18 cases associated with fungal infection.
Aftimos V; Zeinoun T; Bou Tayeh R; Aftimos G
Int J Dent; 2014; 2014():869067. PubMed ID: 24696686
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the Jaws: An Update and Review of Literature.
Kalita F; Gupta DS; Gehlot N; Mitra S; Singh S; Pillai SS
J Maxillofac Oral Surg; 2023 Jun; 22(2):344-351. PubMed ID: 37122785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
